These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6047752)

  • 21. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin C and iron.
    Nienhuis AW
    N Engl J Med; 1981 Jan; 304(3):170-1. PubMed ID: 7442737
    [No Abstract]   [Full Text] [Related]  

  • 23. Current concepts in the overall management of thalassemia.
    Propper RD
    Ann N Y Acad Sci; 1980; 344():375-83. PubMed ID: 6930877
    [No Abstract]   [Full Text] [Related]  

  • 24. MRI and iron-overload cardiomyopathy in thalassaemia.
    Pennell D
    Circulation; 2006 Mar; 113(11):f43-4. PubMed ID: 16552847
    [No Abstract]   [Full Text] [Related]  

  • 25. Absorption of inorganic and food iron in children with heterozygous and homozygous beta-thalassemia.
    Heinrich HC; Gabbe EE; Oppitz KH; Whang DH; Bender-Götze C; Schäfer KH; Schröter W; Pfau AA
    Z Kinderheilkd; 1973 Aug; 115(1):1-22. PubMed ID: 4796508
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of thalassaemia major.
    Modell B
    Br Med Bull; 1976 Sep; 32(3):270-6. PubMed ID: 788837
    [No Abstract]   [Full Text] [Related]  

  • 27. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
    Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current status of treatments with desferrioxamine B in post-transfusion hypersiderosis in children].
    Orsini A; Raybaud C; Bernard PJ; Aquaron R; Passeron P
    Mars Med; 1967; 104(4):331-7. PubMed ID: 5621537
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously].
    Ferrara M; Galdo Capotorti M; Ponte G; Esposito L
    Pediatria (Napoli); 1983; 91(4):371-7. PubMed ID: 6545400
    [No Abstract]   [Full Text] [Related]  

  • 30. The sicca syndrome in thalassaemia major.
    Borgna-Pignatti C; Cammareri V; De Stefano P; Magrini U
    Br Med J (Clin Res Ed); 1984 Mar; 288(6418):668-9. PubMed ID: 6421425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron concentration in teeth of patients with and without beta-thalassaemia major.
    Garfunkel A; Kantzuker M; Gedalia I; Chevion M
    Arch Oral Biol; 1979; 24(10-11):829-31. PubMed ID: 295607
    [No Abstract]   [Full Text] [Related]  

  • 32. Getting the iron out: preventing and treating heart failure in transfusion-dependent thalassemia.
    Jabbar DA; Davison G; Muslin AJ
    Cleve Clin J Med; 2007 Nov; 74(11):807-10, 813-6. PubMed ID: 18020000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Problems related to treatment of beta-thalassaemia major.
    Economidou J
    Paediatrician; 1982; 11(3-4):157-77. PubMed ID: 7043374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic resonance imaging of transfusional hemosiderosis complicating thalassemia major.
    Brasch RC; Wesbey GE; Gooding CA; Koerper MA
    Radiology; 1984 Mar; 150(3):767-71. PubMed ID: 6695078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thalassaemia: clinical management.
    Olivieri N
    Baillieres Clin Haematol; 1998 Mar; 11(1):147-62. PubMed ID: 10872476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinico-therapeutic findings on diabetic complications in thalassemia].
    Colli G; Mariani D; Boffa C; Merisio MG; Terzoli S; Colleoni C; Stucchi C; Biella CA
    Pediatr Med Chir; 1984; 6(6):765-7. PubMed ID: 6545586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of thalassemia and sickle cell anemia in children].
    Girot R
    Ann Pediatr (Paris); 1978; 25(5-6):277-84. PubMed ID: 16114336
    [No Abstract]   [Full Text] [Related]  

  • 38. Partial splenectomy in homozygous beta thalassaemia.
    de Montalembert M; Girot R; Revillon Y; Jan D; Adjrad L; Ardjoun FZ; Belhani M; Najean Y
    Arch Dis Child; 1990 Mar; 65(3):304-7. PubMed ID: 2334210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical studies on iron chelation in patients with thalassemia major.
    Freedman MH; Olivieri N; Benson L; Liu P; McClelland R; St Louis P; Templeton D; Koren G
    Haematologica; 1990; 75 Suppl 5():74-83. PubMed ID: 2086384
    [No Abstract]   [Full Text] [Related]  

  • 40. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ; Grady RW
    Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.